BA
AVNS

Bridgewater Associates’s Avanos Medical AVNS Stock Holding History

Bridgewater Associates’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,471
Closed -$252K – 700
2024
Q3 		$252K Sell
10,471
-5,663
-35% -$129K ﹤0.01% 754
2024
Q2 		$321K Sell
16,134
-1,127
-7% -$21.9K ﹤0.01% 810
2024
Q1 		$344K Sell
17,261
-15,529
-47% -$300K ﹤0.01% 649
2023
Q4 		$735K Sell
32,790
-21,584
-40% -$446K ﹤0.01% 672
2023
Q3 		$1.1M Buy
54,374
+4,516
+9% +$102K 0.01% 591
2023
Q2 		$1.27M Sell
49,858
-6,381
-11% -$168K 0.01% 543
2023
Q1 		$1.67M Buy
56,239
+1,974
+4% +$57.3K 0.01% 488
2022
Q4 		$1.47M Sell
54,265
-18,638
-26% -$456K 0.01% 583
2022
Q3 		$1.59M Sell
72,903
-1,306
-2% -$34.1K 0.01% 607
2022
Q2 		$2.03M Buy
74,209
+6,640
+10% +$191K 0.01% 683
2022
Q1 		$2.26M Buy
67,569
+14,618
+28% +$471K 0.01% 655
2021
Q4 		$1.84M Buy
52,951
+5,735
+12% +$185K 0.01% 475
2021
Q3 		$1.47M Sell
47,216
-2,422
-5% -$82.2K 0.01% 473
2021
Q2 		$1.8M Buy
+49,638
New +$2.05M 0.01% 509

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Bridgewater Associates's AVNS Position: Q4 2024 in Review

Bridgewater Associates sold out of Avanos Medical (AVNS) in Q4 2024, closing a stake of 10,471 shares — an estimated $252K sold.

Bridgewater Associates first reported a position in AVNS in Q2 2021 and held it in 14 quarters. The position peaked at $2.26M in Q1 2022. 258 funds tracked by Wall St. Rank hold AVNS as of Q4 2024.

  • Bridgewater Associates reported no remaining Avanos Medical position as of Q4 2024 after selling out during the quarter.
  • Bridgewater Associates sold 10,471 Avanos Medical shares in Q4 2024, an estimated $252K.
  • Bridgewater Associates first reported a position in Avanos Medical in Q2 2021 and held it in 14 quarters.
  • Bridgewater Associates's Avanos Medical position peaked at $2.26M in Q1 2022.
  • 258 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2024.

Based on Bridgewater Associates's 13F filing for Q4 2024, filed 13 Feb 2025.